Management of the mitral valve in patients with obstructive hypertrophic cardiomyopathy

Joon Hwa Hong1, Anita Nguyen2, Hartzell Vernon Schaff2

  • 1Cardiovascular Surgery, Heart Research Institute, Chung-Ang University College of Medicine, Seoul, Republic of Korea.

Insights

Septal myectomy effectively treats obstructive hypertrophic cardiomyopathy. Mitral valve intervention during this surgery is rarely needed unless intrinsic valve disease is present.

Area of Science:

  • Cardiovascular Surgery
  • Cardiology
  • Cardiac Anatomy

Background:

  • Obstructive hypertrophic cardiomyopathy (oHCM) is a significant cause of morbidity.
  • Septal myectomy is the established surgical treatment for symptomatic oHCM unresponsive to medical therapy.
  • Controversy exists regarding the need for concurrent mitral valve intervention during septal myectomy.

Purpose of the Study:

  • To review the role and necessity of mitral valve intervention in patients undergoing septal myectomy for oHCM.
  • To discuss anatomical considerations, imaging techniques, and surgical strategies for mitral valve management in oHCM.

Main Methods:

  • Review of surgical outcomes and clinical experience at Mayo Clinic with over 3000 septal myectomy procedures.
  • Analysis of anatomical factors influencing mitral valve function in oHCM.
  • Evaluation of imaging modalities for assessing mitral valve pathology in oHCM.

Main Results:

  • Septal myectomy reliably alleviates left ventricular outflow tract obstruction, systolic anterior motion of the mitral valve, and associated regurgitation.
  • Mitral valve operation is infrequently required in patients without intrinsic mitral valve disease (e.g., leaflet prolapse, severe calcific stenosis).
  • Mayo Clinic's extensive experience suggests a conservative approach to mitral valve intervention during myectomy is often appropriate.

Conclusions:

  • Septal myectomy is a highly effective treatment for obstructive hypertrophic cardiomyopathy.
  • Routine mitral valve intervention is not necessary in all patients undergoing septal myectomy.
  • Careful patient selection and assessment for intrinsic mitral valve disease are crucial for guiding surgical decisions.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
146
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
173
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
157
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
229
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
212
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
175